Overview

Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder

Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
0
Participant gender:
All
Summary
Percutaneous Interruption of the Coracohumeral Ligament for the treatment of Frozen Shoulder.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Albert Einstein College of Medicine
Treatments:
Anesthetics
Anesthetics, Local
Criteria
Inclusion Criteria:

- Established Diagnosis of Adhesive capsulitis (AC) Ligament Flavum >3mm, diagnosed by
US evaluation decreased shoulder ROM in external rotation and abduction (50% of
unaffected side)

- Patients who have tried other conventional therapies like steroid treatments, surgical
treatments, physiotherapy with little (defined by less than 20 degrees improvement in
shoulder ROM - external rotation) to no improvement in the shoulder ROM

Exclusion Criteria:

- Age less than 18 years and greater than 89 years

- Patients with AC but showing improvement in shoulder ROM progressively (defined by
improvement in ROM > 200 external rotation or 20 degrees per week when undergoing
physiotherapy)

- Patients who are currently pregnant